| 摘要 |
A novel use for 1 alpha -hydroxylated-19-nor-vitamin D compounds to treat psoriasis inasmuch as these compounds when administered to humans are converted to a metabolite, such as a 1 alpha ,25-dihydroxylated compound, which metabolite in vitro will cause differentiation in a human cell line.
|
